Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹207 Cr
Revenue (TTM)
₹118 Cr
Net Profit (TTM)
₹15 Cr
ROE
23 %
ROCE
21.1 %
P/E Ratio
13.9
P/B Ratio
2.3
Industry P/E
14.4
EV/EBITDA
12.6
Div. Yield
0.2 %
Debt to Equity
0.2
Book Value
₹44.7
EPS
₹7.4
Face value
10
Shares outstanding
20,052,000
CFO
₹-7.18 Cr
EBITDA
₹63.06 Cr
Net Profit
₹48.55 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
| -14.9 | -30.9 | -13.7 | -31.7 | -- | -- | -- |
|
BSE FMCG
| -14.5 | -10.3 | -13.8 | -9.5 | 2.2 | 7.0 | 8.6 |
|
Company
|
2025
|
|---|---|
|
Indo Us Bio-Tech
| -59.4 |
|
BSE Small Cap
| -6.6 |
|
BSE FMCG
| -2.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
|
103.5 | 206.9 | 117.8 | 14.8 | 14.6 | 18 | 13.9 | 2.3 |
| 232.7 | 1,158.6 | 1,378.9 | 101.1 | 9.9 | 13.5 | 11.5 | 1.6 | |
| 153.0 | 3,170.3 | 1,463.4 | 73.6 | 6.1 | 16.3 | 43.1 | 6.1 | |
| 255.0 | 317.2 | 493.3 | 4.4 | 0.5 | 2.7 | 76.6 | 1.9 | |
| 766.4 | 3,940.5 | 1,377.9 | 300.8 | 20.1 | 18.3 | 13.1 | 2.2 | |
| 383.2 | 13,306.7 | 10,267.2 | 636.9 | 9.0 | 16.2 | 20.5 | 3.1 | |
| 3.9 | 423.5 | 1,440.2 | 343.1 | 24.1 | 32.2 | 1.2 | 0.3 | |
| 139.5 | 265.8 | 445.5 | 43.1 | 9.9 | 5.9 | 6.2 | 0.4 | |
| 379.8 | 421.6 | 14.1 | 1.1 | 7.5 | 18.1 | 398.5 | 61.1 | |
| 3.1 | 377.2 | 1,312.7 | 33.1 | 5.1 | 8.6 | 11.4 | 0.8 |
No Review & Analysis are available.
Manufacture of food products
Incorporated
2004
Chairman
--
Managing Director
Jagdish Ajudia
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Indo US Bio-Tech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification sought from Indo Us Bio-Tech Ltd
10-Mar-2026Results- Financial Results For December 31 2025
21-Jan-2026
The share price of Indo US Bio-Tech Ltd is ₹103.49 (NSE) and ₹103.20 (BSE) as of 19-Mar-2026 IST. Indo US Bio-Tech Ltd has given a return of -31.69% in the last 1 years.
The P/E ratio of Indo US Bio-Tech Ltd is 13.95 times as on 19-Mar-2026, a 3 discount to its peers’ median range of 14.40 times.
The P/B ratio of Indo US Bio-Tech Ltd is 2.31 times as on 19-Mar-2026, a 25 premium to its peers’ median range of 1.85 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.15
|
3.76
|
|
2024
|
53.94
|
7.09
|
|
2023
|
14.71
|
3.91
|
|
2022
|
12.22
|
1.61
|
|
2021
|
3.36
|
0.93
|
The 52-week high and low of Indo US Bio-Tech Ltd are Rs 206.00 and Rs 96.05 as of 20-Mar-2026.
Indo US Bio-Tech Ltd has a market capitalisation of ₹ 207 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Indo US Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-3.14
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.